The HSV LAT and its associated microRNA species appear to limit HSV immediate-early (IE) gene expression in vitro [2–4], as well as limiting the accumulation of viral lytic gene transcripts during acute and latent infection of mouse models [5, 6]. This evidence concerns the gene LAT and disease arising from reactivation of latent virus.